Articles On Sigma Healthcare (ASX:SIG)

In afternoon trade on Thursday the S&P/ASX 200 index has followed the lead of U.S. markets and charged higher. At the time of writing the benchmark index is up 0.85% to 6,608.1 points. Four shares that have failed to follow the market...

A cloud-based pharmacy workflow business backed by ASX-listed Sigma Healthcare is out on the hustings seeking to raise fresh capital.

Sigma Healthcare's half-year profit has dropped by two-thirds to $2.52 million as the pharmacy business transitions after losing its Chemist Warehouse contract.

Sigma Healthcare Ltd (ASX: SIG) has just reported its result for the first half of its 2020 financial year. Sigma Pharmaceuticals is a pharmacy distribution business and the name behind Amcal, Chemist King, Discount Drug Stores, Guardian an...

This morning Sigma Healthcare Ltd  (ASX: SIG) released its results for the half-year ending July 31, 2019. Below is a summary of the results with comparisons to the prior corresponding half-year period. Sales revenue $1,878b, -4.1% Report...

The ASX 200 (INDEXASX: XJO)(^AXJO) is expected to open higher today, the USA’s S&P 500 Index (.INX) rose by 1.08% on Wednesday. Australian Dollar ($A) (AUDUSD): 67.96US cents Dow Jones (DJI): up 0.91% Oil (WTI): $US55.92 per barrel Gold...

World Overnight SPI Overnight (Sep) 6555.00 + 19.00 0.29% S&P ASX 200 6553.00 – 20.40 – 0.31% S&P500 2937.78 + 31.51 1.08% Nasdaq Comp 7976.88 + 102.72 1.30% DJIA 26355.47 + 237.45 0.91% S&P500 VIX 17.33 – 2.33 – 1...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

Technology stocks are of those companies that are engaged in research, development and distribution of technology in the form of goods and services. Companies providing hardware, software and gadgets like smartphones in addition to apps, cl...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

According to the World Health Organisation, about $6.5 trillion is spent on the healthcare every year globally. With the global demand for healthcare products and services growing significantly, investment in the healthcare sector seems to...

We reviewed Australian Pharmaceutical Industries (ASX:API) at the end of June and since then the share price has steadily climbed higher. We take another look at the Company’s fundamentals and technical to see whether the shares can make a...

In a country like Australia, where the interest rates are kept very low, high yield dividend stocks are one of the most popular investment opportunities available to the investors. Investments in high yield dividend stocks have the potentia...

**This is an extract from the Market Matters Weekend Report from 14 July. Click here to get access to the full report and more Chart of the week. We preach at almost nauseam that subscribers should remain open-minded with markets and  US eq...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

The global stock markets are extremely sensitive to the global macro-economic conditions and news related to the economic variables. The performance of the global economy can also influence the sentiments of the market players. If the globa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...

International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa...